You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Global Drugs For Herpes Labialis (Oral Herpes) Market Analysis 2016-2020 and Forecast 2021-2026

Snapshot

Herpes Labialis (Oral Herpes) is a type of herpes simplex occurring on the lip, i.e. an infection caused by herpes simplex virus (HSV). An outbreak typically causes small blisters or sores on or around the mouth. The sores typically heal within 2–3 weeks, but the herpes virus remains dormant in the facial nerves, following orofacial infection, periodically reactivating (in symptomatic people) to create sores in the same area of the mouth or face at the site of the original infection.
The global Drugs For Herpes Labialis (Oral Herpes) market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Drugs For Herpes Labialis (Oral Herpes) by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Valacyclovir
Aciclovir
Famciclovir
Docosanol
Others

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
GSK
Novartis
Teva
Mylan
Cadila
Apotex
Daewoong Pharmaceutical
Livzon
Luoxin
Med shine
Bayer (Campho Phenique)
Blistex
Kelun Group
Hikma
Haiwang
Carmex
Cipher

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
External Use
Oral
Injection

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents
1 Industry Overview
1.1 Drugs For Herpes Labialis (Oral Herpes) Industry
Figure Drugs For Herpes Labialis (Oral Herpes) Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Drugs For Herpes Labialis (Oral Herpes)
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Drugs For Herpes Labialis (Oral Herpes)
1.2.2 Downstream
Table Application Segment of Drugs For Herpes Labialis (Oral Herpes)
Table Global Drugs For Herpes Labialis (Oral Herpes) Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Drugs For Herpes Labialis (Oral Herpes) Market by Type
3.1 By Type
3.1.1 Valacyclovir
Table Major Company List of Valacyclovir
3.1.2 Aciclovir
Table Major Company List of Aciclovir
3.1.3 Famciclovir
Table Major Company List of Famciclovir
3.1.4 Docosanol
Table Major Company List of Docosanol
3.1.5 Others
Table Major Company List of Others
3.2 Market Size
Table Global Drugs For Herpes Labialis (Oral Herpes) Market 2016-2020, by Type, in USD Million
Figure Global Drugs For Herpes Labialis (Oral Herpes) Market Growth 2016-2020, by Type, in USD Million
3.3 Market Forecast
Table Global Drugs For Herpes Labialis (Oral Herpes) Market Forecast 2021-2026, by Type, in USD Million
4 Major Companies List
4.1 GSK (Company Profile, Sales Data etc.)
4.1.1 GSK Profile
Table GSK Overview List
4.1.2 GSK Products & Services
4.1.3 GSK Business Operation Conditions
Table Business Operation of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Novartis (Company Profile, Sales Data etc.)
4.2.1 Novartis Profile
Table Novartis Overview List
4.2.2 Novartis Products & Services
4.2.3 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Teva (Company Profile, Sales Data etc.)
4.3.1 Teva Profile
Table Teva Overview List
4.3.2 Teva Products & Services
4.3.3 Teva Business Operation Conditions
Table Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Mylan (Company Profile, Sales Data etc.)
4.4.1 Mylan Profile
Table Mylan Overview List
4.4.2 Mylan Products & Services
4.4.3 Mylan Business Operation Conditions
Table Business Operation of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Cadila (Company Profile, Sales Data etc.)
4.5.1 Cadila Profile
Table Cadila Overview List
4.5.2 Cadila Products & Services
4.5.3 Cadila Business Operation Conditions
Table Business Operation of Cadila (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Apotex (Company Profile, Sales Data etc.)
4.6.1 Apotex Profile
Table Apotex Overview List
4.6.2 Apotex Products & Services
4.6.3 Apotex Business Operation Conditions
Table Business Operation of Apotex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Daewoong Pharmaceutical (Company Profile, Sales Data etc.)
4.7.1 Daewoong Pharmaceutical Profile
Table Daewoong Pharmaceutical Overview List
4.7.2 Daewoong Pharmaceutical Products & Services
4.7.3 Daewoong Pharmaceutical Business Operation Conditions
Table Business Operation of Daewoong Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Livzon (Company Profile, Sales Data etc.)
4.8.1 Livzon Profile
Table Livzon Overview List
4.8.2 Livzon Products & Services
4.8.3 Livzon Business Operation Conditions
Table Business Operation of Livzon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Luoxin (Company Profile, Sales Data etc.)
4.9.1 Luoxin Profile
Table Luoxin Overview List
4.9.2 Luoxin Products & Services
4.9.3 Luoxin Business Operation Conditions
Table Business Operation of Luoxin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Med shine (Company Profile, Sales Data etc.)
4.10.1 Med shine Profile
Table Med shine Overview List
4.10.2 Med shine Products & Services
4.10.3 Med shine Business Operation Conditions
Table Business Operation of Med shine (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Bayer (Campho Phenique) (Company Profile, Sales Data etc.)
4.11.1 Bayer (Campho Phenique) Profile
Table Bayer (Campho Phenique) Overview List
4.11.2 Bayer (Campho Phenique) Products & Services
4.11.3 Bayer (Campho Phenique) Business Operation Conditions
Table Business Operation of Bayer (Campho Phenique) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Blistex (Company Profile, Sales Data etc.)
4.12.1 Blistex Profile
Table Blistex Overview List
4.12.2 Blistex Products & Services
4.12.3 Blistex Business Operation Conditions
Table Business Operation of Blistex (Sales Revenue, Cost, Gross Margin)
4.13 Kelun Group (Company Profile, Sales Data etc.)
4.13.1 Kelun Group Profile
Table Kelun Group Overview List
4.13.2 Kelun Group Products & Services
4.13.3 Kelun Group Business Operation Conditions
Table Business Operation of Kelun Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 Hikma (Company Profile, Sales Data etc.)
4.14.1 Hikma Profile
Table Hikma Overview List
4.14.2 Hikma Products & Services
4.14.3 Hikma Business Operation Conditions
Table Business Operation of Hikma (Sales Revenue, Cost, Gross Margin)
4.15 Haiwang (Company Profile, Sales Data etc.)
4.15.1 Haiwang Profile
Table Haiwang Overview List
4.15.2 Haiwang Products & Services
4.15.3 Haiwang Business Operation Conditions
Table Business Operation of Haiwang (Sales Revenue, Cost, Gross Margin)
4.16 Carmex (Company Profile, Sales Data etc.)
4.16.1 Carmex Profile
Table Carmex Overview List
4.16.2 Carmex Products & Services
4.16.3 Carmex Business Operation Conditions
Table Business Operation of Carmex (Sales Revenue, Cost, Gross Margin)
4.17 Cipher (Company Profile, Sales Data etc.)
4.17.1 Cipher Profile
Table Cipher Overview List
4.17.2 Cipher Products & Services
4.17.3 Cipher Business Operation Conditions
Table Business Operation of Cipher (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Drugs For Herpes Labialis (Oral Herpes) Sales Revenue 2016-2020, by Company, in USD Million
Table Global Drugs For Herpes Labialis (Oral Herpes) Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Drugs For Herpes Labialis (Oral Herpes) Sales Revenue Share in 2020, by Company, in USD Million
5.2 Regional Market by Company
Figure North America Drugs For Herpes Labialis (Oral Herpes) Market Concentration, in 2020
Figure Europe Drugs For Herpes Labialis (Oral Herpes) Market Market Concentration, in 2020
Figure Asia-Pacific Drugs For Herpes Labialis (Oral Herpes) MMarket Concentration, in 2020
Figure South America Drugs For Herpes Labialis (Oral Herpes) Market Concentration, in 2020
Figure Middle East & Africa Drugs For Herpes Labialis (Oral Herpes) Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in External Use
Figure Drugs For Herpes Labialis (Oral Herpes) Demand in External Use, 2016-2020, in USD Million
6.1.2 Demand in Oral
Figure Drugs For Herpes Labialis (Oral Herpes) Demand in Oral, 2016-2020, in USD Million
6.1.3 Demand in Injection
Figure Drugs For Herpes Labialis (Oral Herpes) Demand in Injection, 2016-2020, in USD Million
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Drugs For Herpes Labialis (Oral Herpes) Demand Forecast 2021-2026, by Application, in USD Million
Figure Drugs For Herpes Labialis (Oral Herpes) Market Growth 2021-2026, by Application, in USD Million
Figure Drugs For Herpes Labialis (Oral Herpes) Market Share in 2026, by Application, in USD Million
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Drugs For Herpes Labialis (Oral Herpes) Production 2016-2020, by Region, in USD Million
7.2 Regional Market
Table Global Drugs For Herpes Labialis (Oral Herpes) Market 2016-2020, by Region, in USD Million
Table Global Drugs For Herpes Labialis (Oral Herpes) Market Share 2016-2020, by Region, in USD Million
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Drugs For Herpes Labialis (Oral Herpes) Market Size and Growth 2016-2020, in USD Million
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Drugs For Herpes Labialis (Oral Herpes) Market Size 2016-2020, by Country, in USD Million
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Drugs For Herpes Labialis (Oral Herpes) Market Size and Growth 2016-2020, in USD Million
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Drugs For Herpes Labialis (Oral Herpes) Market Size 2016-2020, by Country, in USD Million
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Drugs For Herpes Labialis (Oral Herpes) Market Size and Growth 2016-2020, in USD Million
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Drugs For Herpes Labialis (Oral Herpes) Market Size 2016-2020, by Country, in USD Million
7.3.4 South America
7.3.4.1 Overview
Figure South America Drugs For Herpes Labialis (Oral Herpes) Market Size and Growth 2016-2020, in USD Million
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Drugs For Herpes Labialis (Oral Herpes) Market Size 2016-2020, by Country, in USD Million
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Drugs For Herpes Labialis (Oral Herpes) Market Size and Growth 2016-2020, in USD Million
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Drugs For Herpes Labialis (Oral Herpes) Market Size 2016-2020, by Country, in USD Million
7.4 Regional Import & Export
7.5 Regional Forecast
Table Drugs For Herpes Labialis (Oral Herpes) Market Forecast 2021-2026, by Region, in USD Million
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
  • FORMAT: PDF
  • PUBLISHED DATE: Feb, 2021
  • NO OF PAGES: 44235